nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Cardiac failure—Etoposide—muscle cancer	0.00694	0.00694	CcSEcCtD
Degarelix—Dysuria—Vincristine—muscle cancer	0.00675	0.00675	CcSEcCtD
Degarelix—Erectile dysfunction—Vincristine—muscle cancer	0.00665	0.00665	CcSEcCtD
Degarelix—Weight decreased—Vincristine—muscle cancer	0.00653	0.00653	CcSEcCtD
Degarelix—Depression—Vincristine—muscle cancer	0.00642	0.00642	CcSEcCtD
Degarelix—Acute coronary syndrome—Vincristine—muscle cancer	0.00635	0.00635	CcSEcCtD
Degarelix—Myocardial infarction—Vincristine—muscle cancer	0.00631	0.00631	CcSEcCtD
Degarelix—Musculoskeletal stiffness—Methotrexate—muscle cancer	0.00623	0.00623	CcSEcCtD
Degarelix—Bone disorder—Methotrexate—muscle cancer	0.00618	0.00618	CcSEcCtD
Degarelix—Abscess—Doxorubicin—muscle cancer	0.00611	0.00611	CcSEcCtD
Degarelix—Chills—Dactinomycin—muscle cancer	0.00581	0.00581	CcSEcCtD
Degarelix—Inflammation—Methotrexate—muscle cancer	0.00576	0.00576	CcSEcCtD
Degarelix—Hypoaesthesia—Vincristine—muscle cancer	0.00575	0.00575	CcSEcCtD
Degarelix—Alopecia—Dactinomycin—muscle cancer	0.00572	0.00572	CcSEcCtD
Degarelix—Urinary tract disorder—Vincristine—muscle cancer	0.00571	0.00571	CcSEcCtD
Degarelix—Urethral disorder—Vincristine—muscle cancer	0.00567	0.00567	CcSEcCtD
Degarelix—Erythema—Dactinomycin—muscle cancer	0.00563	0.00563	CcSEcCtD
Degarelix—Breast pain—Doxorubicin—muscle cancer	0.00554	0.00554	CcSEcCtD
Degarelix—Cardiac disorder—Vincristine—muscle cancer	0.00536	0.00536	CcSEcCtD
Degarelix—Bone disorder—Doxorubicin—muscle cancer	0.00535	0.00535	CcSEcCtD
Degarelix—Angiopathy—Vincristine—muscle cancer	0.00524	0.00524	CcSEcCtD
Degarelix—Ill-defined disorder—Dactinomycin—muscle cancer	0.00523	0.00523	CcSEcCtD
Degarelix—Nocturia—Doxorubicin—muscle cancer	0.00521	0.00521	CcSEcCtD
Degarelix—Mediastinal disorder—Vincristine—muscle cancer	0.00521	0.00521	CcSEcCtD
Degarelix—Anaemia—Dactinomycin—muscle cancer	0.00521	0.00521	CcSEcCtD
Degarelix—Acute coronary syndrome—Etoposide—muscle cancer	0.00514	0.00514	CcSEcCtD
Degarelix—Renal failure—Etoposide—muscle cancer	0.00513	0.00513	CcSEcCtD
Degarelix—Blood bilirubin increased—Doxorubicin—muscle cancer	0.00511	0.00511	CcSEcCtD
Degarelix—Myocardial infarction—Etoposide—muscle cancer	0.00511	0.00511	CcSEcCtD
Degarelix—Alopecia—Vincristine—muscle cancer	0.00511	0.00511	CcSEcCtD
Degarelix—Malaise—Dactinomycin—muscle cancer	0.00508	0.00508	CcSEcCtD
Degarelix—Mental disorder—Vincristine—muscle cancer	0.00506	0.00506	CcSEcCtD
Degarelix—Gynaecomastia—Methotrexate—muscle cancer	0.005	0.005	CcSEcCtD
Degarelix—Inflammation—Doxorubicin—muscle cancer	0.00499	0.00499	CcSEcCtD
Degarelix—Hepatobiliary disease—Etoposide—muscle cancer	0.00493	0.00493	CcSEcCtD
Degarelix—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00489	0.00489	CcSEcCtD
Degarelix—Back pain—Vincristine—muscle cancer	0.00487	0.00487	CcSEcCtD
Degarelix—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.00484	0.00484	CcSEcCtD
Degarelix—Injection site reaction—Doxorubicin—muscle cancer	0.00481	0.00481	CcSEcCtD
Degarelix—Discomfort—Dactinomycin—muscle cancer	0.00474	0.00474	CcSEcCtD
Degarelix—Influenza like illness—Doxorubicin—muscle cancer	0.0047	0.0047	CcSEcCtD
Degarelix—Diabetes mellitus—Methotrexate—muscle cancer	0.00466	0.00466	CcSEcCtD
Degarelix—Hypoaesthesia—Etoposide—muscle cancer	0.00466	0.00466	CcSEcCtD
Degarelix—Anaemia—Vincristine—muscle cancer	0.00465	0.00465	CcSEcCtD
Degarelix—Urinary tract disorder—Etoposide—muscle cancer	0.00462	0.00462	CcSEcCtD
Degarelix—Urethral disorder—Etoposide—muscle cancer	0.00459	0.00459	CcSEcCtD
Degarelix—Eye disorder—Etoposide—muscle cancer	0.00438	0.00438	CcSEcCtD
Degarelix—Cardiac disorder—Etoposide—muscle cancer	0.00435	0.00435	CcSEcCtD
Degarelix—Hypertension—Vincristine—muscle cancer	0.00434	0.00434	CcSEcCtD
Degarelix—Angiopathy—Etoposide—muscle cancer	0.00425	0.00425	CcSEcCtD
Degarelix—Immune system disorder—Etoposide—muscle cancer	0.00423	0.00423	CcSEcCtD
Degarelix—Mediastinal disorder—Etoposide—muscle cancer	0.00422	0.00422	CcSEcCtD
Degarelix—Chills—Etoposide—muscle cancer	0.0042	0.0042	CcSEcCtD
Degarelix—Mental disability—Doxorubicin—muscle cancer	0.0042	0.0042	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00419	0.00419	CcSEcCtD
Degarelix—Alopecia—Etoposide—muscle cancer	0.00414	0.00414	CcSEcCtD
Degarelix—Anaphylactic shock—Vincristine—muscle cancer	0.00411	0.00411	CcSEcCtD
Degarelix—Diabetes mellitus—Doxorubicin—muscle cancer	0.00404	0.00404	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00404	0.00404	CcSEcCtD
Degarelix—Nervous system disorder—Vincristine—muscle cancer	0.00403	0.00403	CcSEcCtD
Degarelix—Decreased appetite—Dactinomycin—muscle cancer	0.004	0.004	CcSEcCtD
Degarelix—Hyperhidrosis—Vincristine—muscle cancer	0.00397	0.00397	CcSEcCtD
Degarelix—Fatigue—Dactinomycin—muscle cancer	0.00396	0.00396	CcSEcCtD
Degarelix—Back pain—Etoposide—muscle cancer	0.00394	0.00394	CcSEcCtD
Degarelix—Pain—Dactinomycin—muscle cancer	0.00393	0.00393	CcSEcCtD
Degarelix—Muscle spasms—Etoposide—muscle cancer	0.00392	0.00392	CcSEcCtD
Degarelix—Hypotension—Vincristine—muscle cancer	0.00384	0.00384	CcSEcCtD
Degarelix—Feeling abnormal—Dactinomycin—muscle cancer	0.00379	0.00379	CcSEcCtD
Degarelix—Ill-defined disorder—Etoposide—muscle cancer	0.00378	0.00378	CcSEcCtD
Degarelix—Anaemia—Etoposide—muscle cancer	0.00377	0.00377	CcSEcCtD
Degarelix—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00376	0.00376	CcSEcCtD
Degarelix—Hot flush—Doxorubicin—muscle cancer	0.00375	0.00375	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00374	0.00374	CcSEcCtD
Degarelix—Menopausal symptoms—Doxorubicin—muscle cancer	0.00372	0.00372	CcSEcCtD
Degarelix—Insomnia—Vincristine—muscle cancer	0.00371	0.00371	CcSEcCtD
Degarelix—Renal impairment—Doxorubicin—muscle cancer	0.00369	0.00369	CcSEcCtD
Degarelix—Malaise—Etoposide—muscle cancer	0.00368	0.00368	CcSEcCtD
Degarelix—Breast disorder—Methotrexate—muscle cancer	0.00366	0.00366	CcSEcCtD
Degarelix—Abdominal pain—Dactinomycin—muscle cancer	0.00363	0.00363	CcSEcCtD
Degarelix—Body temperature increased—Dactinomycin—muscle cancer	0.00363	0.00363	CcSEcCtD
Degarelix—Cardiac failure—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Degarelix—Decreased appetite—Vincristine—muscle cancer	0.00357	0.00357	CcSEcCtD
Degarelix—Gastrointestinal disorder—Vincristine—muscle cancer	0.00355	0.00355	CcSEcCtD
Degarelix—Fatigue—Vincristine—muscle cancer	0.00354	0.00354	CcSEcCtD
Degarelix—Hypertension—Etoposide—muscle cancer	0.00352	0.00352	CcSEcCtD
Degarelix—Pain—Vincristine—muscle cancer	0.00351	0.00351	CcSEcCtD
Degarelix—Constipation—Vincristine—muscle cancer	0.00351	0.00351	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00345	0.00345	CcSEcCtD
Degarelix—Discomfort—Etoposide—muscle cancer	0.00343	0.00343	CcSEcCtD
Degarelix—Hypersensitivity—Dactinomycin—muscle cancer	0.00339	0.00339	CcSEcCtD
Degarelix—Abdominal discomfort—Methotrexate—muscle cancer	0.00336	0.00336	CcSEcCtD
Degarelix—Gastrointestinal pain—Vincristine—muscle cancer	0.00336	0.00336	CcSEcCtD
Degarelix—Anaphylactic shock—Etoposide—muscle cancer	0.00333	0.00333	CcSEcCtD
Degarelix—Asthenia—Dactinomycin—muscle cancer	0.0033	0.0033	CcSEcCtD
Degarelix—Dysuria—Methotrexate—muscle cancer	0.00328	0.00328	CcSEcCtD
Degarelix—Abdominal pain—Vincristine—muscle cancer	0.00325	0.00325	CcSEcCtD
Degarelix—Body temperature increased—Vincristine—muscle cancer	0.00325	0.00325	CcSEcCtD
Degarelix—Skin disorder—Etoposide—muscle cancer	0.00323	0.00323	CcSEcCtD
Degarelix—Erectile dysfunction—Methotrexate—muscle cancer	0.00323	0.00323	CcSEcCtD
Degarelix—Hyperhidrosis—Etoposide—muscle cancer	0.00322	0.00322	CcSEcCtD
Degarelix—Breast disorder—Doxorubicin—muscle cancer	0.00317	0.00317	CcSEcCtD
Degarelix—Diarrhoea—Dactinomycin—muscle cancer	0.00314	0.00314	CcSEcCtD
Degarelix—Depression—Methotrexate—muscle cancer	0.00312	0.00312	CcSEcCtD
Degarelix—Hypotension—Etoposide—muscle cancer	0.00311	0.00311	CcSEcCtD
Degarelix—Muscular weakness—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Degarelix—Renal failure—Methotrexate—muscle cancer	0.00307	0.00307	CcSEcCtD
Degarelix—Hypersensitivity—Vincristine—muscle cancer	0.00303	0.00303	CcSEcCtD
Degarelix—Dyspnoea—Etoposide—muscle cancer	0.00297	0.00297	CcSEcCtD
Degarelix—Hepatobiliary disease—Methotrexate—muscle cancer	0.00295	0.00295	CcSEcCtD
Degarelix—Asthenia—Vincristine—muscle cancer	0.00295	0.00295	CcSEcCtD
Degarelix—Vomiting—Dactinomycin—muscle cancer	0.00292	0.00292	CcSEcCtD
Degarelix—Rash—Dactinomycin—muscle cancer	0.0029	0.0029	CcSEcCtD
Degarelix—Decreased appetite—Etoposide—muscle cancer	0.00289	0.00289	CcSEcCtD
Degarelix—Gastrointestinal disorder—Etoposide—muscle cancer	0.00287	0.00287	CcSEcCtD
Degarelix—Fatigue—Etoposide—muscle cancer	0.00287	0.00287	CcSEcCtD
Degarelix—Pain—Etoposide—muscle cancer	0.00284	0.00284	CcSEcCtD
Degarelix—Constipation—Etoposide—muscle cancer	0.00284	0.00284	CcSEcCtD
Degarelix—Dysuria—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Degarelix—Diarrhoea—Vincristine—muscle cancer	0.00281	0.00281	CcSEcCtD
Degarelix—Pollakiuria—Doxorubicin—muscle cancer	0.0028	0.0028	CcSEcCtD
Degarelix—Urinary tract disorder—Methotrexate—muscle cancer	0.00277	0.00277	CcSEcCtD
Degarelix—Weight increased—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Degarelix—Urethral disorder—Methotrexate—muscle cancer	0.00275	0.00275	CcSEcCtD
Degarelix—Weight decreased—Doxorubicin—muscle cancer	0.00275	0.00275	CcSEcCtD
Degarelix—Feeling abnormal—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Degarelix—Hyperglycaemia—Doxorubicin—muscle cancer	0.00274	0.00274	CcSEcCtD
Degarelix—Nausea—Dactinomycin—muscle cancer	0.00273	0.00273	CcSEcCtD
Degarelix—Gastrointestinal pain—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Degarelix—Dizziness—Vincristine—muscle cancer	0.00272	0.00272	CcSEcCtD
Degarelix—Renal failure—Doxorubicin—muscle cancer	0.00266	0.00266	CcSEcCtD
Degarelix—Urticaria—Etoposide—muscle cancer	0.00264	0.00264	CcSEcCtD
Degarelix—Body temperature increased—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Degarelix—Abdominal pain—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Degarelix—Urinary tract infection—Doxorubicin—muscle cancer	0.00263	0.00263	CcSEcCtD
Degarelix—Eye disorder—Methotrexate—muscle cancer	0.00262	0.00262	CcSEcCtD
Degarelix—Vomiting—Vincristine—muscle cancer	0.00261	0.00261	CcSEcCtD
Degarelix—Cardiac disorder—Methotrexate—muscle cancer	0.0026	0.0026	CcSEcCtD
Degarelix—Rash—Vincristine—muscle cancer	0.00259	0.00259	CcSEcCtD
Degarelix—Dermatitis—Vincristine—muscle cancer	0.00259	0.00259	CcSEcCtD
Degarelix—Headache—Vincristine—muscle cancer	0.00257	0.00257	CcSEcCtD
Degarelix—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Degarelix—Angiopathy—Methotrexate—muscle cancer	0.00254	0.00254	CcSEcCtD
Degarelix—Immune system disorder—Methotrexate—muscle cancer	0.00253	0.00253	CcSEcCtD
Degarelix—Mediastinal disorder—Methotrexate—muscle cancer	0.00253	0.00253	CcSEcCtD
Degarelix—Chills—Methotrexate—muscle cancer	0.00252	0.00252	CcSEcCtD
Degarelix—Alopecia—Methotrexate—muscle cancer	0.00248	0.00248	CcSEcCtD
Degarelix—Mental disorder—Methotrexate—muscle cancer	0.00246	0.00246	CcSEcCtD
Degarelix—Hypersensitivity—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Degarelix—Malnutrition—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Degarelix—Erythema—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Degarelix—Nausea—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Degarelix—Hypoaesthesia—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Degarelix—Urinary tract disorder—Doxorubicin—muscle cancer	0.0024	0.0024	CcSEcCtD
Degarelix—Oedema peripheral—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Degarelix—Asthenia—Etoposide—muscle cancer	0.00239	0.00239	CcSEcCtD
Degarelix—Urethral disorder—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Degarelix—Back pain—Methotrexate—muscle cancer	0.00236	0.00236	CcSEcCtD
Degarelix—Pruritus—Etoposide—muscle cancer	0.00235	0.00235	CcSEcCtD
Degarelix—Vision blurred—Methotrexate—muscle cancer	0.0023	0.0023	CcSEcCtD
Degarelix—Diarrhoea—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Degarelix—Eye disorder—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Degarelix—Ill-defined disorder—Methotrexate—muscle cancer	0.00227	0.00227	CcSEcCtD
Degarelix—Anaemia—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Degarelix—Cardiac disorder—Doxorubicin—muscle cancer	0.00225	0.00225	CcSEcCtD
Degarelix—Angiopathy—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Degarelix—Malaise—Methotrexate—muscle cancer	0.0022	0.0022	CcSEcCtD
Degarelix—Dizziness—Etoposide—muscle cancer	0.0022	0.0022	CcSEcCtD
Degarelix—Immune system disorder—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Degarelix—Mediastinal disorder—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Degarelix—Chills—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Degarelix—Arrhythmia—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Degarelix—Alopecia—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Degarelix—Mental disorder—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Degarelix—Vomiting—Etoposide—muscle cancer	0.00212	0.00212	CcSEcCtD
Degarelix—Erythema—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Degarelix—Malnutrition—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Degarelix—Rash—Etoposide—muscle cancer	0.0021	0.0021	CcSEcCtD
Degarelix—Dermatitis—Etoposide—muscle cancer	0.0021	0.0021	CcSEcCtD
Degarelix—Headache—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Degarelix—Arthralgia—Methotrexate—muscle cancer	0.00208	0.00208	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Degarelix—Discomfort—Methotrexate—muscle cancer	0.00205	0.00205	CcSEcCtD
Degarelix—Back pain—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Degarelix—Muscle spasms—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Degarelix—Anaphylactic shock—Methotrexate—muscle cancer	0.00199	0.00199	CcSEcCtD
Degarelix—Vision blurred—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Degarelix—Nausea—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Degarelix—Ill-defined disorder—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
Degarelix—Nervous system disorder—Methotrexate—muscle cancer	0.00195	0.00195	CcSEcCtD
Degarelix—Anaemia—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Degarelix—Skin disorder—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Degarelix—Hyperhidrosis—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Degarelix—Malaise—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Degarelix—Palpitations—Doxorubicin—muscle cancer	0.00187	0.00187	CcSEcCtD
Degarelix—Hypotension—Methotrexate—muscle cancer	0.00186	0.00186	CcSEcCtD
Degarelix—Hypertension—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Degarelix—Insomnia—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Degarelix—Arthralgia—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Degarelix—Discomfort—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Degarelix—Dyspnoea—Methotrexate—muscle cancer	0.00178	0.00178	CcSEcCtD
Degarelix—Dry mouth—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Degarelix—Decreased appetite—Methotrexate—muscle cancer	0.00173	0.00173	CcSEcCtD
Degarelix—Anaphylactic shock—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Degarelix—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00172	0.00172	CcSEcCtD
Degarelix—Fatigue—Methotrexate—muscle cancer	0.00172	0.00172	CcSEcCtD
Degarelix—Pain—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Degarelix—Nervous system disorder—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Degarelix—Skin disorder—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Degarelix—Hyperhidrosis—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Degarelix—Feeling abnormal—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Degarelix—Gastrointestinal pain—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Degarelix—Hypotension—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Degarelix—Urticaria—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Degarelix—Abdominal pain—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Degarelix—Body temperature increased—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Degarelix—Insomnia—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Degarelix—Dyspnoea—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Degarelix—Decreased appetite—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Degarelix—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Degarelix—Fatigue—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Degarelix—Pain—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Degarelix—Constipation—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Degarelix—Hypersensitivity—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Degarelix—Asthenia—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Degarelix—Feeling abnormal—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Degarelix—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Degarelix—Pruritus—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Degarelix—Urticaria—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Degarelix—Abdominal pain—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Degarelix—Body temperature increased—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Degarelix—Diarrhoea—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Degarelix—Dizziness—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Degarelix—Hypersensitivity—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Degarelix—Vomiting—Methotrexate—muscle cancer	0.00127	0.00127	CcSEcCtD
Degarelix—Rash—Methotrexate—muscle cancer	0.00126	0.00126	CcSEcCtD
Degarelix—Dermatitis—Methotrexate—muscle cancer	0.00126	0.00126	CcSEcCtD
Degarelix—Headache—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Degarelix—Asthenia—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Degarelix—Pruritus—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Degarelix—Nausea—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Degarelix—Diarrhoea—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Degarelix—Dizziness—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Degarelix—Vomiting—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Degarelix—Rash—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Degarelix—Dermatitis—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Degarelix—Headache—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Degarelix—Nausea—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
